Showing results (431-440 of 1,135) with videos related to
Sort By:
Pageof 114
Journal of Hepatocellular Carcinoma|December 11, 2023
Clinical Complete Response After Conversion Therapy for Unresectable Hepatocellular Carcinoma: Is Salvage Hepatectomy Necessary?Jia-Yi Wu, Jun-Yi Wu, De-Yi Liu, et al.Journal of Hepatocellular Carcinoma|November 29, 2023
AHSA1 Regulates Hepatocellular Carcinoma Progression via the TGF-β/Akt-Cyclin D1/CDK6 PathwayYanjun Gao, Yingge Li, Zheming Liu, et al.Journal of Hepatocellular Carcinoma|November 30, 2023
Erratum: Egyptian Society of Liver Cancer Recommendation Guidelines for the Management of Hepatocellular Carcinoma [Corrigendum]Journal of Hepatocellular Carcinoma|January 23, 2024
Monocyte-to-High-Density Lipoprotein-Cholesterol Ratio Predicts Prognosis of Hepatocellular Carcinoma in Patients with Metabolic-Associated Fatty Liver DiseaseTongguo Miao, Xianzhe Lou, Shiming Dong, et al.Journal of Hepatocellular Carcinoma|January 22, 2024
Serum Aldo-Keto Reductase Family 1 Member B10 (AKR1B10) as a Potential Biomarker for Diagnosis of Hepatocellular CarcinomaZiran Wang, Lingjun Kong, Rui Zhang, et al.Journal of Hepatocellular Carcinoma|December 6, 2023
Tenofovir versus Entecavir on Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma After FOLFOX-Hepatic Arterial Infusion ChemotherapyZhikai Zheng, Jiongliang Wang, Tianqing Wu, et al.Journal of Hepatocellular Carcinoma|March 18, 2024
A Hypoxia-Related miRNA-mRNA Signature for Predicting the Response and Prognosis of Transcatheter Arterial Chemoembolization in Hepatocellular CarcinomaShaoqi Zong, Guokai Huang, Bo Pan, et al.Journal of Hepatocellular Carcinoma|March 4, 2024
Risks and Clinical Predictors of Hepatocellular Carcinoma in Chinese Populations: A Real-World Study of 10,359 Patients in Six Medical CentersChenjun Huang, Xiao Xiao, Lin Tong, et al.Journal of Hepatocellular Carcinoma|March 5, 2024
Multiple Machine-Learning Fusion Model Based on Gd-EOB-DTPA-Enhanced MRI and Aminotransferase-to-Platelet Ratio and Gamma-Glutamyl Transferase-to-Platelet Ratio to Predict Microvascular Invasion in Solitary Hepatocellular Carcinoma: A Multicenter StudyFei Wang, Chun Yue Yan, Yuan Qin, et al.Journal of Hepatocellular Carcinoma|February 13, 2024
Lymphocyte-to-C Reactive Protein Ratio is an Independent Predictor of Survival Benefits for Hepatocellular Carcinoma Patients Receiving RadiotherapyZhan Shi, Sihui Zhu, Yuncheng Jin, et al.Pageof 114